These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38271987)

  • 1. Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents.
    Lee E; Kim K; Jeon YH; Sol IS; Kim JD; Min TK; Hwang YH; Cho HJ; Suh DI; Kim HS; Kim YH; Woo SI; Lee YJ; Jung S; Yang HJ; Jang GC
    Clin Exp Pediatr; 2024 Sep; 67(9):418-426. PubMed ID: 38271987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled Medications for Maintenance Therapy in Pediatric Noncystic Fibrosis Bronchiectasis.
    Harvath Gray EM; Pettit RS; Engdahl S
    Ann Pharmacother; 2024 Sep; ():10600280241279602. PubMed ID: 39297217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.
    Lommatzsch ST
    Ther Adv Respir Dis; 2020; 14():1753466620905272. PubMed ID: 32160809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.
    Al-Jahdali H; Alshimemeri A; Mobeireek A; Albanna AS; Al Shirawi NN; Wali S; Alkattan K; Alrajhi AA; Mobaireek K; Alorainy HS; Al-Hajjaj MS; Chang AB; Aliberti S
    Ann Thorac Med; 2017; 12(3):135-161. PubMed ID: 28808486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for bronchiectasis: an overview of Cochrane systematic reviews.
    Welsh EJ; Evans DJ; Fowler SJ; Spencer S
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010337. PubMed ID: 26171905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncystic fibrosis bronchiectasis in children and adolescents: Follow-up over a decade.
    Ullmann N; Porcaro F; Petreschi F; Cammerata M; Allegorico A; Negro V; Cutrera R
    Pediatr Pulmonol; 2021 Sep; 56(9):3026-3034. PubMed ID: 34265867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncystic fibrosis bronchiectasis management: opportunities and challenges.
    Kocurek EG; Jagana R
    Curr Opin Pulm Med; 2019 Mar; 25(2):192-200. PubMed ID: 30640187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.
    Kapur N; Masters IB; Chang AB
    Respir Med; 2009 Nov; 103(11):1681-7. PubMed ID: 19501498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Delphi study of pharmacotherapy for noncystic fibrosis bronchiectasis.
    Judson MA; Chaudhry H; Compa DR; OʼDonnell AE
    Am J Med Sci; 2014 Nov; 348(5):387-93. PubMed ID: 24992394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic strategies for treating bronchiectasis in pediatric patients.
    Lee E; Hong SJ
    Expert Opin Pharmacother; 2019 Jun; 20(8):1025-1036. PubMed ID: 30897021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-management for bronchiectasis.
    Kelly C; Grundy S; Lynes D; Evans DJ; Gudur S; Milan SJ; Spencer S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012528. PubMed ID: 29411860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mannose-binding lectin 2 gene polymorphisms on disease severity in noncystic fibrosis bronchiectasis in children.
    Dogru D; Polat SE; Tan Ç; Tezcan İ; Yalçın SS; Utine E; Oğuz B; Yaz İ; Emiralioğlu N; Hızal M; Yalçın E; Özçelik U; Çağdaş D; Kiper N
    Pediatr Pulmonol; 2020 May; 55(5):1190-1198. PubMed ID: 32119194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
    Chang AB; Fortescue R; Grimwood K; Alexopoulou E; Bell L; Boyd J; Bush A; Chalmers JD; Hill AT; Karadag B; Midulla F; McCallum GB; Powell Z; Snijders D; Song WJ; Tonia T; Wilson C; Zacharasiewicz A; Kantar A
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33542057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of antibiotic therapy in non-cystic fibrosis bronchiectasis.
    Somayaji R; Goss CH
    Curr Pulmonol Rep; 2019 Dec; 8(4):160-165. PubMed ID: 31875166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography.
    Gürel E; Vezir D; Güçtekin T; Doğan Z; Kocakaya D; Olgun S; Sünbül M; Çinçin A; Özben B; Sayar N; Tigen MK; Ceyhan B
    Anatol J Cardiol; 2023 Jun; 27(6):319-327. PubMed ID: 37257004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent prophylactic antibiotics for bronchiectasis.
    Spencer S; Donovan T; Chalmers JD; Mathioudakis AG; McDonnell MJ; Tsang A; Leadbetter P
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013254. PubMed ID: 34985761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials.
    Chang AB; Zacharasiewicz A; Goyal V; Boyd J; Alexopoulou E; Aliberti S; Bell L; Bush A; Claydon A; Constant C; Fortescue R; Hill AT; Karadag B; Powell Z; Wilson C; Grimwood K; Kantar A; ; Chalmers J; Collaro A; Douros K; Griese M; Grigg J; Hector A; Mazulov O; Midulla F; Möller A; Proesmans M; Yerkovich S
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35728974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.
    Wang D; Fu W; Dai J
    Medicine (Baltimore); 2019 Apr; 98(17):e15285. PubMed ID: 31027086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.